App Intel

Ramadan Risk Rate

LiveKCompute (Private) Limited2 apps · 2.5K installsHealth & FitnessFreecom.ramadanriskrate

A risk Assessment Calculator for Diabetic Patients who Fast during Ramadan

Alert me★ WatchOpen in Play ↗
Total installs
370
exact · Play shows 100+
Installs / day
0
since last crawl
Rating
—★
— ratings · — reviews
Released
12 Apr 2018
8.5y ago
Last update
2 Dec 2025
v1.1 · 10mo ago
Countries
—
not checked yet

Install history

exact counter from Google Play
361.4396.1430.7465.450010 Oct11 Oct12 Oct
361.4396.1430.7465.450010 Oct11 Oct12 Oct

Installs per day · last 90 days

00.30.50.8111 Oct12 Oct12 Oct11 Oct: 012 Oct: 0

Change timeline

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

Country data will be available soon.

We estimate where downloads come from using the app’s position in Google Play’s top charts in about 140 countries. This app is not in any chart we have collected yet; the estimate appears as soon as it is.

Top chart positions

Not in any tracked top chart.

App manifest

Read this app's manifest from Google Play: permissions, declared SDKs, components and AdMob app ID. Saved analysis appears here automatically.

Manifest analysis reads only the required APK ranges. Base APK downloads may need separate device splits to install.

Store listing

Full description
RRR INFORMATION A risk Assessment Calculator for Diabetic Patients who Fast during Ramadan This Ramadan Risk Rate stratification tool is based on a classification model that can be used quickly and accurately to grade diabetic patients into various categories using patient anthropometric, clinical and biochemical data. Each component is given points according to the degree of risk it poses during Ramadan fasting to the diabetic patient. This tool will be useful for healthcare practitioners in evaluating the level of risk of their diabetic patients quickly and noninvasively and subsequently plan future strategy accordingly. In this application is also incorporated further management strategies of individual patients. This is based on the risk score the patient achieves. Depending on the score patients are categorized into low, moderate or high-risk group. Thus the management is individualized according to the risk grade. Based on the information obtained at the time of presentation , patients are Risk stratified according to evidence based risk criteria including gender , age, profession , type, duration and control of diabetes, complications both acute and chronic, co-morbid conditions and treatment they are receiving .Each risk criteria is given points depending on the level of the risk. Finally each patient is given a cumulative score based on the ten predetermined criteria and thus stratified as, Low Risk, Moderate Risk, High Risk and Very High Risk. References .Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A, the EPIDIAR Study Group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27: 2306–2311, 2004 .Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim 8 MA, et al. American Diabetes Association recommendations for management of diabetes during Ramadan. Diabetes Care 2005;28:2305-11. .Clark M. Diabetes self management education: a review of published studies. Prim Care Diabetes 2008; 2: 113-20. .International Diabetes Federation. Diabetes Education. IDF: Brussels; 2009. .Al Sifri S, Basiounny A, Echtay A, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: A randomised trial. Int J Clin Pract 2011;65:1132-40. . Hassan A, Meo SA, Usmani AM, Shaikh TJ. Diabetes during Ramadan - PRE-approach model: presentation, risk stratification, education. Eur Rev Med Pharmacol Sci. 2014;18(12):1798-805 .Babineaux SM, Toaima D, Boye KS, et al. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 2015;32:819-28. .Diabetes and Ramadan: Practical Guidelines International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance April 2016

What's new

Compatibility updates and bug fixes.

Growing in Health & Fitness

Category →